Depo Provera Mass Tort Case Leads
Reach women who developed meningioma or other intracranial tumors after receiving medroxyprogesterone acetate (Depo Provera) injections for contraception.
Depo Provera Litigation
Depo Provera is an injectable contraceptive containing medroxyprogesterone acetate, manufactured by Pfizer. Recent studies have established a strong association between prolonged Depo Provera use and an increased risk of developing meningioma, a type of brain tumor that forms on the membranes surrounding the brain and spinal cord. Lawsuits allege the manufacturer knew or should have known about this risk and failed to provide adequate warnings to patients and healthcare providers.
Associated Conditions
- Meningioma (brain tumors)
- Intracranial tumors
- Headaches and vision changes
- Seizures
- Neurological impairment
- Surgical intervention for tumor removal
- Hearing loss or cognitive decline
Claimant Eligibility
- Received Depo Provera injections for one year or longer
- Diagnosed with meningioma or intracranial tumor
- Tumor diagnosis occurred during or after Depo Provera use
- Required surgery, radiation, or ongoing monitoring for the tumor
- Medical records confirming Depo Provera prescription history
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Depo Provera legal marketing campaigns: how we acquire cases
Depo Provera case acquisition runs as a multi-channel program, not a single ad buy. Product liability and class action claimants research their condition long before they contact a lawyer, so we meet potential clients at each stage — paid demand capture for people already searching, paid social and traditional media for people who have not yet connected their injury to the litigation, and organic search for the long research tail.
Digital marketing channels
- Google Ads and paid search demand capture
- Meta and paid social prospecting by exposure profile
- Mass tort search engine optimization for the research tail
- OTT and connected TV retargeting
Traditional media channels
- Broadcast and cable TV in qualifying DMAs
- Radio and streaming audio
- Direct response print in occupational verticals
- Earned media and litigation PR support
How the channel mix is built, budgeted, and measured is covered in our mass tort marketing guide. For intake handling once the lead lands, see mass tort intake.
Depo Provera Lawsuit Updates (March 2026)
Current status of the Depo Provera litigation, tracked monthly so your intake team and marketing spend stay aligned with where the docket actually is.
- MDL
- MDL 3140
- Court
- N.D. Fla.
- Pending cases
- 2,098
- Reported
- February 2026
Current posture: Fast-growing docket; meningioma claims consolidated in 2025.
The Depo-Provera docket grew by roughly 1,001 cases between February and March — a 47.7% month-over-month increase, one of the steepest growth rates in any active MDL this year.
The JPML MDL statistics report dated February 2 recorded 2,098 actions pending in MDL 3140, against 2,123 total historical actions.
The JPML report of September 2 indicated 806 Depo-Provera lawsuits pending, marking the early consolidation phase of the meningioma litigation.
Case counts and procedural posture are compiled from JPML MDL statistics reporting and public court dockets, and are provided for law firm campaign planning. This is not legal advice and is not a prediction of any case outcome.
Running a Depo Provera mass tort marketing campaign
Common questions from law firms about Depo Provera lawsuit lead generation and campaign management.
- What does a Depo Provera mass tort marketing campaign include?
- A Depo Provera mass tort marketing campaign from Mass Tort Marketing Agency covers multi-channel strategy across Meta, Google PPC, OTT and connected TV, traditional media, and mass tort search engine optimization; compliant ad creative; TCPA-verified intake; claimant qualification against your Depo Provera case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
- How do you generate Depo Provera mass tort case leads?
- Depo Provera mass tort case leads are generated through paid social and search campaigns aimed at the specific exposure and injury profile of the litigation, supported by organic content that captures claimants already researching their condition. Every lead is a real, consented claimant — we do not buy aggregated lists or resell shared data.
- What do Depo Provera legal marketing campaigns cost?
- Depo Provera legal marketing campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. Cost per retainer varies by tort based on claimant prevalence, media competition, and how tight your case criteria are. We scope a per-tort figure before any spend commitment.
- Are Depo Provera leads exclusive to my firm?
- Yes. Every Depo Provera lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are Depo Provera claimants qualified before delivery?
- Each Depo Provera claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a certified TrustedForm or Jornaya consent record — preserving the exact disclosure language shown at submission — before the lead reaches your intake team.
- How fast can a Depo Provera case acquisition program scale?
- A Depo Provera mass tort case acquisition program typically moves from scoping to live media inside two weeks, with volume ramped against your docket capacity rather than pushed to a fixed budget. Volume can be scaled up or down by tort month to month as the litigation posture changes.
Get Depo Provera campaign pricing on a 30-minute call
We will walk your Depo Provera case criteria, current cost per signed retainer, and the volume your docket can absorb — and tell you plainly if this tort is not a fit right now.
See how every lead is qualified on our mass tort leads page, read the full mass tort marketing guide, or compare providers in our top mass tort marketing firms guide.